Popular Articles

Jul 02, 2018
Pharmaceutical Executive
Pharm Exec’s 18th annual listing of the top biopharma players shows that most of the familiar placeholders are holding their ground as they weigh a changing business climate with new opportunities for growth.
Jun 18, 2018
Pharmaceutical Executive
Weighing the crossover effect of US’s new pricing blueprint. 
Jun 10, 2018
Pharmaceutical Executive
There is no magic bullet that will dramatically impact drug pricing to everybody’s liking. But a stepwise approach involving a series of reforms, including taking advantage of the next midterm elections, could point the path toward a solution.
Mar 16, 2018
James Burt, Accord Healthcare’s EVP, Europe and MENA, outlines his optimistic vision for the UK and Europe post-Brexit and the challenges of retaining a company culture amid major growth.
Feb 12, 2018
Pharmaceutical Executive
The biotech sector has managed to elude the negative perceptions saddling traditional pharma these days. We examine the reasons why.
Feb 12, 2018
Pharmaceutical Executive
Lieutenant General (Ret) Rick Lynch, US Army, and Bob Jansen, CEO of Zensights, discuss the military-industry effort to instill the principles of adaptive leadership into today’s pharma leader.
Feb 12, 2018
Pharmaceutical Executive
Whether the pharma industry is navigating calm or choppy waters, it should be smarter and more assertive in telling its story to its stakeholders—most importantly, patients and the wider public.
Feb 11, 2018
Jin Zhang reviews the current fortunes of the Chinese pharmaceutical companies.
Feb 11, 2018
Pharmaceutical Executive
In this Q&A, Richard Lajoie, the new head of Valeant Canada, shares his main priorities for the business, including growing its domestic manufacturing as a key cog globally.
Jan 26, 2018
Pharmaceutical Executive
In our annual temperature check on the life sciences sector and its outlook for the months ahead, we explore eight trends that will shape the biopharma industry landscape in 2018.
native1_300x100
lorem ipsum